Loading…
CMIC Group
Japan's pioneer CRO with comprehensive pharmacovigilance.
About
CRO pharmacovigilance division delivering ICSR processing, signal detection, aggregate reporting, medical review and J-QPPV / local-QPPV services with strong PMDA expertise.
Deterministic scores · rules-based, not AIiHow these scores are obtained: each one is computed from this profile's listed attributes — capability checkboxes, certifications, capacity figures and coverage — by a fixed formula, recomputed on every page load. Deterministic and rules-based means the score comes from a fixed, transparent formula over listed attributes — the same inputs always produce the same score. It is not AI: there is no model, no learning, and no hidden weighting. Whether a score is relevant to you depends on your specific project: a capability that raises the number may not matter for your work, and a niche strength your project needs may barely move it. Capability scores are a directional starting point, not a verdict. A lower score does not disqualify a company or consultant, and no decision should rest on the score alone — always contact the company directly to confirm the specifics for your project.
PV capability iCounts how many of the 13 core PV service capabilities this profile lists (ICSR processing, SAE handling, signal detection and more) - each adds 4 points, capped at 52 - plus 2.5 points per therapeutic area covered, capped at 30, and a case-volume capacity tier worth up to 18 (18 at 1M+ cases/yr, 14 at 500K+, 10 at 200K+, 6 at 50K+, 3 for any volume). Levels: 80+ Comprehensive PV | 60-79 Broad capability | 40-59 Established | below 40 Focused. Whether this dimension matters for you depends on your specific project.
67Broad capability
Regulatory reach iAdds 5 points per regulatory agency covered, capped at 45, plus 18 points for global QPPV support, 12 for local QPPV support and 5 for QPPV availability, and 6 points per geographic region covered, capped at 25. Levels: 80+ Global reach | 60-79 Multi-region | 40-59 Regional | below 40 Limited. Whether this dimension matters for you depends on your specific project.
79Multi-region
Safety technology iAdds 12 points per safety database or analytics platform listed, capped at 48, plus 22 points for AI-assisted safety monitoring, 16 for signal detection capability and 14 for signal management. Levels: 80+ Cutting-edge | 60-79 Advanced | 40-59 Developing | below 40 Foundational. Whether this dimension matters for you depends on your specific project.
88Cutting-edge
Aggregate reporting iAdds 7 points per aggregate report type offered (PSUR, PBRER, DSUR etc.), capped at 40, plus 7 points per risk-management service, capped at 30, then 16 points for medical review capability and 14 for benefit-risk assessment. Levels: 80+ Comprehensive | 60-79 Strong | 40-59 Solid | below 40 Basic. Whether this dimension matters for you depends on your specific project.
93Comprehensive
Quality & compliance iBlends on-time submission rate (0.3 points per percent, up to 30), average case processing speed (20 points at 3 days or less, 15 at 5 or less, 9 at 8 or less, else 3), compliance flags (GxP 14, ISO 10, GDPR 8, HIPAA 8) and audit findings last year (10 points for zero, 7 for one, 3 for up to three). Shows Not reported when no submission rate, processing time, ISO or GxP data is on file. Levels: 80+ Exceptional | 60-79 Strong | 40-59 Solid | below 40 Developing. Whether this dimension matters for you depends on your specific project.
32Developing
Capacity & scale iTiers the PV professional headcount up to 30 points (30 at 1500+, 24 at 500+, 17 at 150+, 10 at 40+), annual case-volume capacity up to 28 (28 at 1M+, 22 at 500K+, 15 at 200K+, 9 at 50K+) and active clients up to 22 (22 at 200+, 17 at 80+, 11 at 25+, 6 at 5+), plus 5 points per geographic region covered, capped at 20. Levels: 80+ Enterprise scale | 60-79 Large | 40-59 Mid-size | below 40 Boutique. Whether this dimension matters for you depends on your specific project.
20Boutique
Therapeutic areas
OncologyCardiovascularNeurologyInfectious diseaseVaccinesRare disease
Regulatory agencies
PMDAFDAEMAMHRA
Geographic coverage
JapanUSAEuropeGlobal
Global locations
Tokyo, JapanHQOsaka, JapanHubPrinceton, NJ, USAHub
Live record · illustrative seed data · scores deterministic, rules-based — not AI.